Back to Search
Start Over
Therapeutic Drug Monitoring of antibiotic and antifungical drugs in paediatric and newborn patients. Consensus Guidelines of the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Paediatric Infectious Diseases (SEIP).
- Source :
-
Anales de pediatria [An Pediatr (Engl Ed)] 2024 Sep; Vol. 101 (3), pp. 190-207. - Publication Year :
- 2024
-
Abstract
- Therapeutic monitoring of antibiotics and antifungals based on pharmacokinetic and pharmacodynamic (PK/PD) parameters is a strategy increasingly used for the optimization of therapy to improve efficacy, reduce the occurrence of toxicities, and prevent the selection of antimicrobial resistance, particularly in vulnerable patients including neonates and the critical or immunocompromised paediatric host. In neonates and children, infections account for a high percentage of hospital admissions, and anti-infectives are the most used drugs. However, paediatric PK/PD studies and the evidence regarding the efficacy and safety of some newly marketed antibiotics and antifungals-usually used off-label in paediatrics-to determine the optimal drug dosage regimens are limited. It is widely known that this population presents important differences in the PK parameters (especially in drug clearance and volume of distribution) in comparison with adults that may alter antimicrobial exposure and, therefore, compromise treatment success. In addition, paediatric patients are more susceptible to potential adverse drug effects and they need closer monitoring. The aim of this document, developed jointly by the Spanish Society of Hospital Pharmacy and the Spanish Society of Paediatric Infectious Diseases, is to describe the available evidence on the indications for therapeutic drug monitoring (TDM) of antibiotics and antifungals in newborn and paediatric patients, and to provide practical recommendations for TDM in routine clinical practice to optimise their dosing, efficacy and safety. Of antibiotics and antifungals in the paediatric population.<br />Competing Interests: Declaration of competing interest The authors declare that they have no conflict of interest regarding the content of this consensus document.<br /> (Copyright © 2024 The Author(s). Published by Elsevier España, S.L.U. All rights reserved.)
- Subjects :
- Humans
Infant, Newborn
Child
Infant
Child, Preschool
Drug Monitoring methods
Anti-Bacterial Agents pharmacokinetics
Anti-Bacterial Agents administration & dosage
Anti-Bacterial Agents therapeutic use
Antifungal Agents pharmacokinetics
Antifungal Agents administration & dosage
Antifungal Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 2341-2879
- Volume :
- 101
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Anales de pediatria
- Publication Type :
- Academic Journal
- Accession number :
- 39278690
- Full Text :
- https://doi.org/10.1016/j.anpede.2024.05.001